Enveric Biosciences (ENVB) Operating Margin Growth (5y) (2019 - 2020)

Enveric Biosciences (ENVB) Operating Margin Growth (5y) (2019 - 2020) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.41 Bn	131.56 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.14 Bn	78.15 Bn	3.93 Bn
3	Argenx Se	65.52 Bn	60.34 Bn	1.37 Bn
4	Moderna	58.21 Bn	53.07 Bn	52.00 Mn
5	BeOne Medicines	42.15 Bn	37.05 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.62 Bn	28.31 Bn	992.69 Mn
7	BioNTech SE	27.95 Bn	9.56 Bn	668.28 Mn
8	Insmed	27.48 Bn	26.32 Bn	358.27 Mn
9	Royalty Pharma	27.30 Bn	26.46 Bn	-
10	Enveric Biosciences	5.72 Mn	-2.57 Mn	-

Download Data